Disclaimer: Please note that the distribution of these products is limited to qualified investors (as defined in section 86(7) of the Financial Services and Markets Act 2000) only. Those not categorised as such (professional client or eligible counterparty) according to the MiFID rules, are not eligible to invest in this type of securities through Bowsprit Partners.
Conduit Pharmaceuticals Ltd
Type: Convertible Note Programme
request more info
Level 1, Devonshire House, One Mayfair Place, W1J 8AJ, London, United Kingdom
© 2022 Bowsprit Partners Limited - Level 1, Devonshire House, One Mayfair Place, W1J 8AJ, London, United Kingdom
Bowsprit Partners Limited is authorised and regulated by the Financial Conduct Authority (FRN 403139)
Building investment opportunities in the real economy